Perlmutter Cancer Center

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

• Conditions:
  Endometrial Cancer
• Age: Between 18 years - 100 years
• Gender: Female

• Other Inclusion Criteria:
  

  1) Patient has histologically or cytologically proven endometrial cancer with recurrent or advanced disease. 2) Patient must have primary Stage III or Stage IV disease or first recurrent endometrial cancer with a low potential for cure by radiation therapy or surgery alone or in combination.
  

You may not be eligible for this study if the following are true:

• 1) Patient has received neo-adjuvant/adjuvant systemic chemotherapy for primary Stage III or IV disease and: has not had a recurrence or progression of disease prior to entering the study OR has had a recurrence or progression of disease within 6 months of completing chemotherapy treatment prior to entering the study 2) Patient has had > 1 recurrence of endometrial cancer. 3) Patient has received prior therapy with an anti-PD-1, anti-PD-L1, or anti-PD-L2 agent (immunotherapy drugs).